Nadofaragene firadenovec, sold under the brand name adstiladrin, is a gene therapy for the treatment of bladder cancer This medicine is to be used only by or under the direct supervision of a doctor. Includes adstiladrin side effects, interactions and indications.
It delivers a copy of the gene encoding ifnα2b to the bladder urothelium resulting in local expression of the ifnα2b protein for anti. It is a recombinant adenovirus serotype 5 vector containing a.
